These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 34963613)

  • 1. Combination of Neutrophil-to-Lymphocyte Ratio and Red Cell Distribution Width With Serum Tumor Markers for the Differential Diagnosis of Breast Cancer and its Association With Pathological Features and Molecular Types.
    Zou H; Liu SH; Yang R; Wu XJ; Cao YP; Huang HF
    Clin Breast Cancer; 2022 Jun; 22(4):e526-e535. PubMed ID: 34963613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The diagnostic value of serum tumor markers CEA, CA19-9, CA125, CA15-3, and TPS in metastatic breast cancer.
    Wang W; Xu X; Tian B; Wang Y; Du L; Sun T; Shi Y; Zhao X; Jing J
    Clin Chim Acta; 2017 Jul; 470():51-55. PubMed ID: 28457854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Clinical Significance of sICAM-1 in Differentiating Benign Breast Lesions from Breast Cancer.
    Chen C; Chen Q; Dong Y; Liu X
    Ann Clin Lab Sci; 2020 Sep; 50(5):650-656. PubMed ID: 33067211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FTO, PIK3CB serve as potential markers to complement CEA and CA15-3 for the diagnosis of breast cancer.
    Mi J; Zhang H; Cao W; Yuan C
    Medicine (Baltimore); 2023 Oct; 102(42):e35361. PubMed ID: 37861518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The predictive value of preoperative serum neutrophil-to-lymphocyte ratio and tumor markers for early breast cancer patients: A retrospective study.
    Fan S; Xie X; Shen Y; Wang W; Gu X; Yao Z
    Medicine (Baltimore); 2022 Aug; 101(32):e30011. PubMed ID: 35960055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The value of NLR, FIB, CEA and CA19-9 in colorectal cancer].
    Qian X; Wang H; Ren Z; Jin F; Pan SY
    Zhonghua Yu Fang Yi Xue Za Zhi; 2021 Apr; 55(4):499-505. PubMed ID: 33858062
    [No Abstract]   [Full Text] [Related]  

  • 7. The value of red blood cell distribution width, neutrophil-to-lymphocyte ratio, and hemoglobin-to-red blood cell distribution width ratio in the progression of non-small cell lung cancer.
    Chen JL; Wu JN; Lv XD; Yang QC; Chen JR; Zhang DM
    PLoS One; 2020; 15(8):e0237947. PubMed ID: 32833961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma mammaglobin messenger RNA in breast cancer patients as an addition to serum tumor.
    El-Attar NI; Gaefar HA
    Egypt J Immunol; 2007; 14(2):111-21. PubMed ID: 20306663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the importance of the serum levels of CA-125, CA15-3, CA-19-9, carcinoembryonic antigen and alpha fetoprotein for distinguishing benign and malignant adnexal masses and contribution of different test combinations to diagnostic accuracy.
    Bozkurt M; Yumru AE; Aral I
    Eur J Gynaecol Oncol; 2013; 34(6):540-4. PubMed ID: 24601047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Preoperative Serum Levels of CEA and CA15-3 with Molecular Subtypes of Breast Cancer.
    Zhao W; Li X; Wang W; Chen B; Wang L; Zhang N; Wang Z; Yang Q
    Dis Markers; 2021; 2021():5529106. PubMed ID: 34621407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative red cell distribution width and neutrophil-to-lymphocyte ratio predict survival in patients with epithelial ovarian cancer.
    Li Z; Hong N; Robertson M; Wang C; Jiang G
    Sci Rep; 2017 Feb; 7():43001. PubMed ID: 28223716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Independent prognostic impact of preoperative serum carcinoembryonic antigen and cancer antigen 15-3 levels for early breast cancer subtypes.
    Imamura M; Morimoto T; Nomura T; Michishita S; Nishimukai A; Higuchi T; Fujimoto Y; Miyagawa Y; Kira A; Murase K; Araki K; Takatsuka Y; Oh K; Masai Y; Akazawa K; Miyoshi Y
    World J Surg Oncol; 2018 Feb; 16(1):26. PubMed ID: 29433529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of hemoglobin-to-red blood cell distribution width ratio (Hb/RDW), neutrophil-to-lymphocyte ratio (NLR), and platelet-to-lymphocyte ratio (PLR) for the diagnosis of nasopharyngeal cancer.
    Lin Z; Zhang X; Luo Y; Chen Y; Yuan Y
    Medicine (Baltimore); 2021 Jul; 100(28):e26537. PubMed ID: 34260530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic Value of Serum Concentration and Integrity of Circulating Cell-Free DNA in Breast Cancer: A Comparative Study With CEA and CA15-3.
    Tang Z; Li L; Shen L; Shen X; Ju S; Cong H
    Lab Med; 2018 Oct; 49(4):323-328. PubMed ID: 29701836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of TPS, CA125, CA15-3 and CEA in prediction of distant metastasis of breast cancer.
    Zhang J; Wei Q; Dong D; Ren L
    Clin Chim Acta; 2021 Dec; 523():19-25. PubMed ID: 34454906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic performances of methylated septin9 gene, CEA, CA19-9 and platelet-to-lymphocyte ratio in colorectal cancer.
    Sun Q; Long L
    BMC Cancer; 2024 Jul; 24(1):906. PubMed ID: 39068425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of multiple biological indicators for combined diagnosis of gastric cancer: A retrospective analysis.
    Zhao Q; Dong L; Liang H; Pang K; Wang P; Ge R; Li T; Jiang S; Chu Y
    Medicine (Baltimore); 2022 Nov; 101(47):e31904. PubMed ID: 36451446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thioredoxin 1 as a serum marker for breast cancer and its use in combination with CEA or CA15-3 for improving the sensitivity of breast cancer diagnoses.
    Park BJ; Cha MK; Kim IH
    BMC Res Notes; 2014 Jan; 7():7. PubMed ID: 24393391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential value of serum chemerin in patients with breast cancer.
    Song Y; Zhu X; Lin Z; Luo L; Wen D
    Sci Rep; 2021 Mar; 11(1):6564. PubMed ID: 33753802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Red cell distribution width and neutrophil-lymphocyte ratio in rheumatoid arthritis.
    Remalante PPM; Salido EO; Penserga EG; Gauiran DTV
    Rheumatol Int; 2020 Oct; 40(10):1631-1637. PubMed ID: 32812079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.